Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 38

1.

Patient-reported outcomes from a randomized phase III trial of sarilumab monotherapy versus adalimumab monotherapy in patients with rheumatoid arthritis.

Strand V, Gossec L, Proudfoot CWJ, Chen CI, Reaney M, Guillonneau S, Kimura T, van Adelsberg J, Lin Y, Mangan EK, van Hoogstraten H, Burmester GR.

Arthritis Res Ther. 2018 Jun 19;20(1):129. doi: 10.1186/s13075-018-1614-z.

2.

Two years of sarilumab in patients with rheumatoid arthritis and an inadequate response to MTX: safety, efficacy and radiographic outcomes.

Genovese MC, van Adelsberg J, Fan C, Graham NMH, van Hoogstraten H, Parrino J, Mangan EK, Spindler A, Huizinga TWJ, van der Heijde D; EXTEND study investigators.

Rheumatology (Oxford). 2018 Aug 1;57(8):1423-1431. doi: 10.1093/rheumatology/key121.

3.

Sarilumab and Nonbiologic Disease-Modifying Antirheumatic Drugs in Patients With Active Rheumatoid Arthritis and Inadequate Response or Intolerance to Tumor Necrosis Factor Inhibitors.

Fleischmann R, van Adelsberg J, Lin Y, Castelar-Pinheiro GD, Brzezicki J, Hrycaj P, Graham NM, van Hoogstraten H, Bauer D, Burmester GR.

Arthritis Rheumatol. 2017 Feb;69(2):277-290. doi: 10.1002/art.39944.

4.

Efficacy and safety of sarilumab monotherapy versus adalimumab monotherapy for the treatment of patients with active rheumatoid arthritis (MONARCH): a randomised, double-blind, parallel-group phase III trial.

Burmester GR, Lin Y, Patel R, van Adelsberg J, Mangan EK, Graham NM, van Hoogstraten H, Bauer D, Ignacio Vargas J, Lee EB.

Ann Rheum Dis. 2017 May;76(5):840-847. doi: 10.1136/annrheumdis-2016-210310. Epub 2016 Nov 17.

6.

Sarilumab Plus Methotrexate in Patients With Active Rheumatoid Arthritis and Inadequate Response to Methotrexate: Results of a Phase III Study.

Genovese MC, Fleischmann R, Kivitz AJ, Rell-Bakalarska M, Martincova R, Fiore S, Rohane P, van Hoogstraten H, Garg A, Fan C, van Adelsberg J, Weinstein SP, Graham NM, Stahl N, Yancopoulos GD, Huizinga TW, van der Heijde D.

Arthritis Rheumatol. 2015 Jun;67(6):1424-37. doi: 10.1002/art.39093.

7.

Sarilumab, a fully human monoclonal antibody against IL-6Rα in patients with rheumatoid arthritis and an inadequate response to methotrexate: efficacy and safety results from the randomised SARIL-RA-MOBILITY Part A trial.

Huizinga TW, Fleischmann RM, Jasson M, Radin AR, van Adelsberg J, Fiore S, Huang X, Yancopoulos GD, Stahl N, Genovese MC.

Ann Rheum Dis. 2014 Sep;73(9):1626-34. doi: 10.1136/annrheumdis-2013-204405. Epub 2013 Dec 2.

8.

Clinical studies of the DP1 antagonist laropiprant in asthma and allergic rhinitis.

Philip G, van Adelsberg J, Loeys T, Liu N, Wong P, Lai E, Dass SB, Reiss TF.

J Allergy Clin Immunol. 2009 Nov;124(5):942-8.e1-9. doi: 10.1016/j.jaci.2009.07.006. Epub 2009 Sep 12.

PMID:
19748656
9.

Systematic review of trials of the effect of continued use of oral non-selective NSAIDs on blood pressure and hypertension.

Morrison A, Ramey DR, van Adelsberg J, Watson DJ.

Curr Med Res Opin. 2007 Oct;23(10):2395-404. Review.

PMID:
17714606
10.

The VIOXX in Prostate Cancer Prevention study: cardiovascular events observed in the rofecoxib 25 mg and placebo treatment groups.

van Adelsberg J, Gann P, Ko AT, Damber JE, Logothetis C, Marberger M, Schmitz-Drager BJ, Tubaro A, Harms CJ, Roehrborn C.

Curr Med Res Opin. 2007 Sep;23(9):2063-70.

PMID:
17651539
11.

Onset and duration of protection against exercise-induced bronchoconstriction by a single oral dose of montelukast.

Pearlman DS, van Adelsberg J, Philip G, Tilles SA, Busse W, Hendeles L, Loeys T, Dass SB, Reiss TF.

Ann Allergy Asthma Immunol. 2006 Jul;97(1):98-104.

PMID:
16892789
12.

Safety, tolerability, and exploratory efficacy of montelukast in 6- to 24-month-old patients with asthma.

van Adelsberg J, Moy J, Wei LX, Tozzi CA, Knorr B, Reiss TF.

Curr Med Res Opin. 2005 Jun;21(6):971-9.

PMID:
15969897
13.

Pharmacokinetics of montelukast in asthmatic patients 6 to 24 months old.

Migoya E, Kearns GL, Hartford A, Zhao J, van Adelsberg J, Tozzi CA, Knorr B, Deutsch P.

J Clin Pharmacol. 2004 May;44(5):487-94.

PMID:
15102869
14.

Montelukast for treating fall allergic rhinitis: effect of pollen exposure in 3 studies.

Chervinsky P, Philip G, Malice MP, Bardelas J, Nayak A, Marchal JL, van Adelsberg J, Bousquet J, Tozzi CA, Reiss TF.

Ann Allergy Asthma Immunol. 2004 Mar;92(3):367-73.

PMID:
15049402
15.

Montelukast improves symptoms of seasonal allergic rhinitis over a 4-week treatment period.

van Adelsberg J, Philip G, Pedinoff AJ, Meltzer EO, Ratner PH, Menten J, Reiss TF; Montelukast Fall Rhinitis Study Group.

Allergy. 2003 Dec;58(12):1268-76. Erratum in: Allergy. 2004 Mar;59(3):357. Allergy. 2009 Nov;64(11):1697.

PMID:
14616102
16.

Randomized controlled trial evaluating the clinical benefit of montelukast for treating spring seasonal allergic rhinitis.

van Adelsberg J, Philip G, LaForce CF, Weinstein SF, Menten J, Malice MP, Reiss TF; Montelukast Spring Rhinitis Investigator Group.

Ann Allergy Asthma Immunol. 2003 Feb;90(2):214-22.

PMID:
12602669
17.

Activation of hepatocyte growth factor (HGF) by endogenous HGF activator is required for metanephric kidney morphogenesis in vitro.

van Adelsberg J, Sehgal S, Kukes A, Brady C, Barasch J, Yang J, Huan Y.

J Biol Chem. 2001 May 4;276(18):15099-106. Epub 2000 Oct 13.

18.

Cardiac defects and renal failure in mice with targeted mutations in Pkd2.

Wu G, Markowitz GS, Li L, D'Agati VD, Factor SM, Geng L, Tibara S, Tuchman J, Cai Y, Park JH, van Adelsberg J, Hou H Jr, Kucherlapati R, Edelmann W, Somlo S.

Nat Genet. 2000 Jan;24(1):75-8.

PMID:
10615132
19.

Polycystin-1 interacts with E-cadherin and the catenins--clues to the pathogenesis of cyst formation in ADPKD?

van Adelsberg J.

Nephrol Dial Transplant. 2000 Jan;15(1):1-2. Review. No abstract available.

PMID:
10607757
20.
21.

The role of the polycystins in kidney development.

van Adelsberg JS.

Pediatr Nephrol. 1999 Jun;13(5):454-9. Review.

PMID:
10412869
23.

Protein targeting: the molecular basis of vectorial transport in the kidney.

van Adelsberg J.

Semin Nephrol. 1998 Mar;18(2):152-66. Review.

PMID:
9541270
24.

The effect of apical and basolateral lipids on the function of the band 3 anion exchange protein.

van't Hof W, Malik A, Vijayakumar S, Qiao J, van Adelsberg J, Al-Awqati Q.

J Cell Biol. 1997 Nov 17;139(4):941-9.

25.

Protection of perfused lung from oxidant injury by inhibitors of anion exchange.

Nozik-Grayck E, Piantadosi CA, van Adelsberg J, Alper SL, Huang YC.

Am J Physiol. 1997 Aug;273(2 Pt 1):L296-304.

PMID:
9277440
26.

Polycystin expression is temporally and spatially regulated during renal development.

Van Adelsberg J, Chamberlain S, D'Agati V.

Am J Physiol. 1997 May;272(5 Pt 2):F602-9.

PMID:
9176370
27.

Analysis of the role of membrane polarity in polycystic kidney disease of transgenic SBM mice.

Barisoni L, Trudel M, Chrétien N, Ward L, van Adelsberg J, D'Agati V.

Am J Pathol. 1995 Dec;147(6):1728-35.

28.

The PKD1 gene product.

Harris PC, Germino G, Klinger K, Landes G, van Adelsberg J.

Nat Med. 1995 Jun;1(6):493. No abstract available.

PMID:
7585106
29.

The PKD1 gene produces a developmentally regulated protein in mesenchyme and vasculature.

Van Adelsberg JS, Frank D.

Nat Med. 1995 Apr;1(4):359-64.

PMID:
7585067
30.
31.

An induced extracellular matrix protein reverses the polarity of band 3 in intercalated epithelial cells.

van Adelsberg J, Edwards JC, Takito J, Kiss B, al-Awqati Q.

Cell. 1994 Mar 25;76(6):1053-61.

PMID:
8137422
32.

The apical Cl/HCO3 exchanger of beta intercalated cells.

van Adelsberg JS, Edwards JC, al-Awqati Q.

J Biol Chem. 1993 May 25;268(15):11283-9.

33.

Conditional immortalization of bicarbonate-secreting intercalated cells from rabbit.

Edwards JC, van Adelsberg J, Rater M, Herzlinger D, Lebowitz J, al-Awqati Q.

Am J Physiol. 1992 Aug;263(2 Pt 1):C521-9.

PMID:
1325122
34.

Isolation and culture of HCO3- -secreting intercalated cells.

Van Adelsberg J, Edwards JC, Herzlinger D, Cannon C, Rater M, al-Awqati Q.

Am J Physiol. 1989 May;256(5 Pt 1):C1004-11.

PMID:
2541617
35.

Measurement of pH of intracellular compartments in living cells by fluorescent dyes.

van Adelsberg J, Barasch J, al-Awqati Q.

Methods Enzymol. 1989;172:85-95. No abstract available.

PMID:
2747547
36.

Regulation of cell pH by Ca+2-mediated exocytotic insertion of H+-ATPases.

van Adelsberg J, Al-Awqati Q.

J Cell Biol. 1986 May;102(5):1638-45.

37.

Carbon-dioxide-induced exocytotic insertion of H+ pumps in turtle-bladder luminal membrane: role of cell pH and calcium.

Cannon C, van Adelsberg J, Kelly S, Al-Awqati Q.

Nature. 1985 Apr 4-10;314(6010):443-6.

PMID:
2858819
38.

Plant cell suspension cultures sustain long-term replication of potato spindle tuber viroid.

Zelcer A, van Adelsberg J, Leonard DA, Zaitlin M.

Virology. 1981 Mar;109(2):314-22.

PMID:
18635038

Supplemental Content

Loading ...
Support Center